TrialJournal of neuro-oncology2024

Iron-based biomarkers for personalizing pharmacological ascorbate therapy in glioblastoma: insights from a phase 2 clinical trial.

M S Petronek et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.